Zdrowie i gospodarka · 12/01/2023
FDA Releases Draft Guidance for Photobiomodulation Devices
The FDA has made available a draft guidance document outlining recommendations for premarket submissions for photobiomodulation devices, which are used in various medical applications, including aesthetics and dermatology.
Source: Federal Register — Food and Drug AdministrationOpen original release →